Answers are grounded in this paper and cite their sources.
Breast cancer is a prevalent and highly fatal disease worldwide. Although gene therapy faces several challenges, including limited selectivity, immune rejection, and low transport efficiency, it remains a promising therapeutic approach for breast cancer. Exosomes, which are naturally derived nanocarriers secreted by various cells, have garnered significant interest for their role in gene delivery. These exosomes are capable of effectively transporting nucleic acids, such as siRNA, circRNA, mRNA, miRNA, and DNA, to target cells, thereby influencing their biological functions. These exosomes are very suitable for gene therapy due to their little immunogenicity, exceptional design flexibility, and compatibility with living organisms. The objective of this research is to conduct a comprehensive analysis of the present condition of exosome-mediated gene delivery for treating breast cancer, including its benefits and drawbacks. In this article, we provide an overview of the characteristics and formation of These exosomes and their role in the initiation, dissemination, and resistance to therapy in breast cancer. Here, we provide a summary of the current methods and strategies for encoding nucleic acids into These exosomes, together with the factors affecting their transportation’s accuracy and effectiveness. In addition, we discuss several types of nucleic acid exosomes used in breast cancer therapy, along with their mechanisms of action and outcomes. Furthermore, we highlight the recent developments and applications of exosome-based delivery nanoplatforms, which combine exosomes with other nanomaterials or biomolecules to enhance their stability, targeting, and functionality. Finally, we present the current status and challenges of exosome-based clinical trials and the future perspectives and potential clinical applications of exosome-based gene delivery nanoplatforms. This review seeks to provide valuable insights and recommendations for advancing and refining exosome-based gene delivery strategies in breast cancer treatment.
No takes yet. Share an insight, caveat, or question.
Kangarshahi et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: